Category Archives: General HIV- population
Reviews on HIV- people that explore topics including risk, screening, and prevention
Dental care as a risk factor for transfusion transmissible infections in blood donors: A systematic review and meta-analysis
BACKGROUND AND OBJECTIVES: The deferral policy for blood donation after dental care is based on the precautionary principle. The aim of this systematic review is to give an overview of...
Fracture-related infections in HIV infected patients: A systematic review and meta-analysis
Aim: To conduct a systematic review and meta-analysis comparing the incidence of fracture-related infections (FRI) following surgical management of closed and open fractures in HIV-positive and HIV-negative patients. Methods: A...
Verification of HIV self-testing use and results: A global systematic review
HIV self-testing (HIVST) allows individuals to interpret and report their own test results, thus decentralizing testing. Yet, this decentralization can make it difficult to verify self-testing results, which is important...
Therapeutic use of cannabis and cannabinoids: An evidence mapping and appraisal of systematic reviews
BACKGROUND: Although cannabis and cannabinoids are widely used with therapeutic purposes, their claimed efficacy is highly controversial. For this reason, medical cannabis use is a broad field of research that...
Community engagement interventions for communicable disease control in low- and lower- middle-income countries: Evidence from a review of systematic reviews
BACKGROUND: Community engagement (CE) interventions include a range of approaches to involve communities in the improvement of their health and wellbeing. Working with communities defined by location or some other...
Neurocysticercosis and HIV Infection: What can we learn from the published literature?
OBJECTIVE: Infections caused by the human immunodeficiency virus (HIV) and by the larvae of Taenia solium (i.e., cysticercosis) are still widespread in many developing countries. Both pathologies modify host immune...
Barriers to the wider use of pre-exposure prophylaxis in the United States: A narrative review
Antiretroviral pre-exposure prophylaxis (PrEP) to prevent HIV transmission was first approved by the US Food and Drug Administration in 2012. Despite correlations of decreases in new HIV infections being greatest...